C - Chemistry – Metallurgy – 12 – Q
Patent
C - Chemistry, Metallurgy
12
Q
C12Q 1/68 (2006.01) A61K 31/70 (2006.01) A61K 39/395 (2006.01)
Patent
CA 2316364
A method of disease prognosis which involves determining the genotype of a human or non-human mammal subject for at least one Fc receptor, and identifiying whether the determined genotype corresponds to a benign or non- benign prognosis for a disease selected from multiple sclerosis, myasthenia gravis, diabetes mellitus, cerebrovascular and cardiovascular diseases, atherosclerosis, and Addison's disease.
L'invention concerne une méthode pronostique qui consiste à déterminer le génotype d'un sujet humain ou mammifère non humain, pour au moins un récepteur Fc, et à établir si le génotype déterminé correspond à un pronostic bénin ou non bénin pour une maladie choisie parmi la sclérose en plaques, la myasthénie grave, le diabète sucré, les maladies cérébrovasculaires et cardiovasculaires, l'athérosclérose et la maladie d'Addison.
Myhr Kjell-Morten
Nyland Harold Inge
Vedeler Christian Alexander
Fetherstonhaugh & Co.
Stiftelsen Universitetsforskning Bergen (unifob)
LandOfFree
Method for disease prognosis based on fc receptor genotyping does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for disease prognosis based on fc receptor genotyping, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for disease prognosis based on fc receptor genotyping will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1419055